Medbox to Provide Advisory Services To Manufacturer of Branded Cannabis-based Medicinal Tablets

IRVINE, CA / ACCESSWIRE / December 1, 2015 / Medbox, Inc. (OTCQB: MDBX), a provider of specialized services to the cannabis sector, including operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved, today announced it will provide manufacturing advisory services and oversight for PrimaCan, a manufacturer of branded cannabis-based medicinal tablets sold to medical marijuana dispensaries, principally in Southern California.

As part of its services, Medbox will lease a facility in Orange County, California, to house the manufacturing operations, as PrimaCan expands production and distribution of its branded edible products. PrimaCan was founded in 2013 and currently manufactures six products, sold under prescription, for pain management and other medical indications.

“We are pleased to help PrimaCan enhance its industry presence and provide its quality branded products to an increasing number of patients,” said Goh. “At the same time, we view our work with PrimaCan as providing opportunity for Medbox to achieve another viable, ongoing stream of revenues.”

About Medbox, Inc.

Medbox, Inc., a leader in the rapidly emerging cannabis sector, provides specialized services to operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved. Through trusted clients and affiliates, the company promotes efficient, consistent, high quality products that are priced right, readily available and safely packaged. For more information about the company or to explore partnership, please visit www.medbox.com.

Forward-Looking Statements

Certain statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements, including, but not limited to, achieving another viable revenue stream, are based on current beliefs and expectations and are inherently subject to significant business, economic, regulatory and competitive uncertainties and contingencies, many of which are beyond the company’s control. In addition, certain forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties also include, but are not limited to, regulatory developments in the industry, as well as political and economic conditions present within the industry. For a more detailed description of the risk factors associated with the company, please refer to the company’s latest Annual Report on Form 10-K, and in particular, the section entitled “Risk Factors” therein, and in other periodic reports the company files with the Securities and Exchange Commission thereafter. The company does not assume any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made, unless required by law.

For more information about Medbox, contact:

Janet Simmons
PondelWilkinson Inc.
310-279-5980
pwinvestor@pondel.com

SOURCE: Medbox, Inc.

ReleaseID: 434190